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each one-year period were randomly selected.
Of 200 patients reviewed in the pre-intervention group, 126 (63%) were female, the mean age was 79.6 years. 128 (64%) had 6 or fewer falls, 140 (70%) had less than 5 medications, 118 (59%) were on analgesics, 134 (67%) on cardiovascular drugs, 32 (16%) received anxiolytics, 82 (41%) received sedatives, and 54 (27%) received other psychoactive medication.
Of 200 patients reviewed in the post-intervention group, 132 (66%) were female, the mean age was 78.5 years, 140 (70%) had 6 or fewer falls, 128(64%) had less than 5 medications, 126 (63%) were on analgesics, 150 (75%) on cardiovascular drugs, 32 (16%) received anxiolytics, 72 (36%) received sedatives, and 66 (33%) received other psychoactive medication.
Study design
This was a single-centre, retrospective, observational study that included those patients in the rehabilitation centre, and compared outcomes before and after the intervention implementation in a random group of patients whose charts were reviewed and selected for inclusion.
Analysis of effectiveness
The primary health outcomes used in the analysis were the patient fall rate (number of patient falls ? 1000/patient day) and the classes and number of drugs in the drug regimen. No blinding for outcome assessment was reported. Statistical tests were performed to analyse differences in demographic characteristics, those with previous falls or not, and drug classes, as well as the intervention effectiveness. There were no significant differences in demographic and clinical characteristics between the groups at baseline.
Effectiveness results
The number of falls reduced from 30 patients in the pre-intervention group to 16 in the post-intervention group, representing a 47% reduction, (p=0.05).
For the post-intervention group, patient falls decreased as use of medications decreased. Decreases in drug classes were as follows: cardiovascular, 10.7%; analgesics, 6.3%; psychoactive, 18.2%; and sedatives and hypnotics, 13.9%. The authors did not report whether differences were significant.
The authors reported that the intervention had a more significant effect on female patients, but these data were not presented.
Clinical conclusions
Implementation of an FFPIP decreased falls by 47% and decreased the use of cardiovascular drugs, analgesics, and psychoactive medications among elderly patients in a nursing home.
Measure of benefits used in the economic analysis
A cost-consequences analysis (CCA) was performed, and therefore no summary measure of benefit was used in the economic evaluation.
Direct costs
Although the authors stated that the study was analysed from a patient and payer perspective, cost categories were not reported. Quantities and costs were not reported separately. The sources of quantity and cost data were not reported. Discounting was not reported, but this was appropriate since costs were incurred over a period of less than 2 years. The price year was not reported.
